NEW YORK (GenomeWeb News) – Life Technologies' full-year 2013 revenues increased 2 percent year over year, Thermo Fisher Scientific said today in a document filed with the US Securities and Exchange Commission.

Life Tech posted $3.87 billion in revenues, up from $3.80 billion in 2012. Its net income increased to $470.4 million from $430.4 million, Thermo Fisher said. It did not report Life Tech's EPS figure.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.